011HO01479 ROYALTY

Print/PDF
Registration Name LEKKER VALIANT ROYALTY
Registration Number HOUSA000001821208
Primary NAAB Code 011HO01479
Secondary Code(s)
Status Inactive
Controller Name Alta Genetics (11)
Date of Birth 1/16/1980
aAa -
DMS -
GFI 4.6%
Genetic Codes * TV TL TD
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T, HCD-T
Sire S-W-D VALIANT
MGS MOWRY-K IMPERIAL KNIGHT
Beta Casein -
Kappa Casein -
Beta Lactoglobulin -
INDEXES
NM$ -1272, 92% R CM$ -1293
NM Percentile 00% FM$ -1231
GTPI 879 GM$ -1257
PRODUCTION TRAITS
18866 Dtrs 5656 herds 100 % US 99% R
Milk -2027 Fat, % -133 , -0.20%
SCS 3.44, 99% R Protein, % -69 , -0.01%
Feed Saved -36 , 58% R Milking Speed 7.1 , 59% R
Health & Fertility
Productive Life -5.0      99% R Mastitis -2.3      88% R
Heifer Livability -0.8       57% R Metritis -1.6      83% R
Livability -1.6      99% R D. Abom -0.4      86% R
DPR -1.1      99% R Ketosis -1.8      81% R
FSC -5.3      98% R R. Placenta -0.2      84% R
HCR -0.3      89% R Milk Fever 0.2      68% R
CCR -1.4      98% R
SCR -        -
DIA -       40% R
RSP 1.0      45% R
Calving Traits
Sire CE 1.5      99% R 8337 Obs
Daughter CE 2.9      99% R 8638 Obs, 4706 Dtrs
Sire SB 3.9      99% R 5738 Obs
Daughter SB 5.9      99% R 4917 Obs, Dtrs
Gestation Length 1.2      91% R 5 Obs, 8 Dtrs
Early First Calving -4.3      99% R 4697 Obs, 14530 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
8764 Dtrs 3386 herds 99% R
PTA Type -3.70 UDC -5.23
HCC -7.80 BWC -0.80
FLC -1.25
Linear Traits
Stature -2.42
Short
Strength -0.95
Weak
Body Depth -1.01
Shallow
Dairy Form -1.66
Closed
Rump Angle 0.98
Sloped
Thurl Width -1.52
Sloped
Rear Legs-Side View -1.52
Narrow
Rear Legs-Rear View -2.11
H.-in
Foot Angle -1.16
Low
Feet & Legs Score -1.55
Low
F.U. Attachment -0.82
Straight
Rear Udder Height -7.31
Low
Rear Udder Width -5.20
Narrow
Udder Cleft -2.92
Weak
Udder Depth -2.11
H.-in
Front Teat Placement -1.37
Wide
Rear Teat Placement -2.01
Wide
Teat Length 0.78
Long
-2
0
2

CDCB August 2026; Base of Evaluation: HO